Kolon TissueGene Decides on 47.8 Billion KRW Paid-in Capital Increase

Kolon TissueGene announced on the 23rd that it has decided to conduct a paid-in capital increase worth 47.8 billion KRW to secure operating funds.

The company will issue 762,350 common shares at 62,460 KRW per share through a third-party allotment. The third-party allotment target is Kolon Co., Ltd., the largest shareholder.

Regarding the selection process, the company stated, "The allocation was made considering the investor's intention and payment capability to achieve management objectives and raise funds."